BOD1L2
gene geneOn this page
Also known as MGC33608
Summary
BOD1L2 (biorientation of chromosomes in cell division 1 like 2, HGNC:28505) is a protein-coding gene on chromosome 18q21.31, encoding Biorientation of chromosomes in cell division protein 1-like 2 (Q8IYS8). May play a role in proper chromosome biorientation through the detection or correction of syntelic attachments in mitotic spindles.
Predicted to be involved in cell division. Predicted to be located in centrosome; cytoplasm; and kinetochore.
Source: NCBI Gene 284257 — RefSeq curated summary.
At a glance
- GWAS associations: 1
- Clinical variants (ClinVar): 5 total — 1 pathogenic
- MANE Select transcript:
NM_001257964
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:28505 |
| Approved symbol | BOD1L2 |
| Name | biorientation of chromosomes in cell division 1 like 2 |
| Location | 18q21.31 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | MGC33608 |
| Ensembl gene | ENSG00000228075 |
| Ensembl biotype | protein_coding |
| Entrez | 284257 |
Gene structure
Transcript identifiers
Ensembl transcripts: 1 — 1 protein_coding
ENST00000585477
RefSeq mRNA: 1 — MANE Select: NM_001257964
NM_001257964
CCDS: CCDS59322
Canonical transcript exons
ENST00000585477 — 1 exons
| Exon | Start | End |
|---|---|---|
| ENSE00002942000 | 57147087 | 57150410 |
Expression profiles
Bgee: expression breadth broad, 63 present calls, max score 99.91.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 1.6248 / max 1652.7754, expressed in 16 samples.
FANTOM5 promoters (3 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 170343 | 1.2739 | 8 |
| 170344 | 0.3113 | 4 |
| 170345 | 0.0397 | 9 |
Top tissues by expression
215 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| sperm | CL:0000019 | 99.91 | gold quality |
| adult organism | UBERON:0007023 | 99.30 | gold quality |
| left testis | UBERON:0004533 | 98.55 | gold quality |
| right testis | UBERON:0004534 | 98.44 | gold quality |
| testis | UBERON:0000473 | 95.85 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 86.16 | gold quality |
| oocyte | CL:0000023 | 75.60 | gold quality |
| secondary oocyte | CL:0000655 | 71.13 | silver quality |
| kidney epithelium | UBERON:0004819 | 69.62 | gold quality |
| cauda epididymis | UBERON:0004360 | 68.46 | gold quality |
| epithelial cell of pancreas | CL:0000083 | 66.29 | gold quality |
| buccal mucosa cell | CL:0002336 | 64.30 | gold quality |
| pancreatic ductal cell | CL:0002079 | 63.44 | silver quality |
| cerebellar vermis | UBERON:0004720 | 63.24 | gold quality |
| tibialis anterior | UBERON:0001385 | 60.79 | silver quality |
| caput epididymis | UBERON:0004358 | 58.62 | gold quality |
| epithelium of nasopharynx | UBERON:0001951 | 56.06 | gold quality |
| amniotic fluid | UBERON:0000173 | 55.29 | gold quality |
| cardiac muscle of right atrium | UBERON:0003379 | 54.34 | gold quality |
| left ventricle myocardium | UBERON:0006566 | 54.23 | gold quality |
| upper arm skin | UBERON:0004263 | 53.52 | gold quality |
| deltoid | UBERON:0001476 | 52.08 | gold quality |
| corpus epididymis | UBERON:0004359 | 51.94 | gold quality |
| myocardium | UBERON:0002349 | 50.25 | gold quality |
| quadriceps femoris | UBERON:0001377 | 48.48 | gold quality |
| ileal mucosa | UBERON:0000331 | 48.32 | silver quality |
| thymus | UBERON:0002370 | 47.79 | silver quality |
| nasal cavity epithelium | UBERON:0005384 | 47.03 | gold quality |
| upper leg skin | UBERON:0004262 | 46.75 | silver quality |
| vastus lateralis | UBERON:0001379 | 45.93 | gold quality |
Single-cell (SCXA)
Detected in 2 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-GEOD-134144 | yes | 31.54 |
| E-ANND-3 | no | 1.64 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
105 targeting BOD1L2, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-6833-3P | 100.00 | 70.63 | 3197 |
| HSA-MIR-4768-5P | 100.00 | 69.49 | 2861 |
| HSA-MIR-9-5P | 100.00 | 72.28 | 2361 |
| HSA-MIR-4668-3P | 100.00 | 68.74 | 2635 |
| HSA-MIR-371A-3P | 99.99 | 66.77 | 91 |
| HSA-MIR-4775 | 99.98 | 75.00 | 6394 |
| HSA-MIR-12136 | 99.98 | 72.81 | 5713 |
| HSA-MIR-520D-5P | 99.98 | 73.34 | 4883 |
| HSA-MIR-524-5P | 99.98 | 73.43 | 4882 |
| HSA-MIR-607 | 99.97 | 73.62 | 5593 |
| HSA-MIR-3148 | 99.97 | 75.06 | 6478 |
| HSA-MIR-590-3P | 99.96 | 74.34 | 6478 |
| HSA-MIR-1250-3P | 99.96 | 70.04 | 4038 |
| HSA-MIR-651-3P | 99.94 | 73.48 | 5177 |
| HSA-MIR-539-5P | 99.93 | 70.30 | 2855 |
| HSA-MIR-1297 | 99.91 | 73.41 | 3162 |
| HSA-MIR-454-3P | 99.91 | 74.01 | 1925 |
| HSA-MIR-3671 | 99.90 | 73.04 | 3897 |
| HSA-MIR-130A-3P | 99.90 | 73.31 | 1861 |
| HSA-MIR-130B-3P | 99.90 | 73.27 | 1850 |
| HSA-MIR-301A-3P | 99.90 | 73.15 | 1839 |
| HSA-MIR-301B-3P | 99.90 | 73.19 | 1836 |
| HSA-MIR-3666 | 99.90 | 73.24 | 1833 |
| HSA-MIR-4295 | 99.90 | 73.11 | 1838 |
| HSA-MIR-548E-5P | 99.89 | 72.73 | 4486 |
| HSA-MIR-9902 | 99.89 | 69.15 | 2250 |
| HSA-MIR-4671-3P | 99.88 | 72.46 | 1045 |
| HSA-MIR-182-5P | 99.87 | 74.03 | 2589 |
| HSA-MIR-6124 | 99.87 | 69.78 | 3551 |
| HSA-MIR-5582-3P | 99.86 | 72.48 | 4221 |
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Bod1 | ENSMUSG00000044502 |
| rattus_norvegicus | Bod1 | ENSRNOG00000020717 |
Paralogs (2): BOD1L1 (ENSG00000038219), BOD1 (ENSG00000145919)
Protein
Protein identifiers
Biorientation of chromosomes in cell division protein 1-like 2 — Q8IYS8 (reviewed: Q8IYS8)
Alternative names: Biorientation of chromosomes in cell division protein 1 pseudogene, Protein FAM44C
All UniProt accessions (1): Q8IYS8
UniProt curated annotations — full annotation on UniProt →
Function. May play a role in proper chromosome biorientation through the detection or correction of syntelic attachments in mitotic spindles.
Subcellular location. Cytoplasm. Cytoskeleton. Microtubule organizing center. Centrosome. Chromosome. Centromere. Kinetochore.
Similarity. Belongs to the BOD1 family.
RefSeq proteins (1): NP_001244893* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR043244 | BOD1L1 | Family |
| IPR055264 | BOD1/SHG1_dom | Domain |
Pfam: PF05205
UniProt features (6 total): region of interest 2, compositionally biased region 2, chain 1, sequence conflict 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q8IYS8-F1 | 75.49 | 0.17 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 39 (showing top):
GOCC_MICROTUBULE_ORGANIZING_CENTER, GOCC_CENTROSOME, GOCC_CHROMOSOMAL_REGION, GOBP_CELL_DIVISION, GOCC_CONDENSED_CHROMOSOME_CENTROMERIC_REGION, chr18q21, GOCC_SUPRAMOLECULAR_COMPLEX, MIR607, MIR651_3P, MIR548E_5P, MIR3671, MIR1297, MIR1250_3P, MIR182_5P, MIR4251
GO Biological Process (1): cell division (GO:0051301)
GO Molecular Function (1): protein binding (GO:0005515)
GO Cellular Component (6): kinetochore (GO:0000776), centrosome (GO:0005813), chromosome, centromeric region (GO:0000775), chromosome (GO:0005694), cytoplasm (GO:0005737), cytoskeleton (GO:0005856)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| intracellular membraneless organelle | 3 |
| cellular process | 1 |
| binding | 1 |
| condensed chromosome, centromeric region | 1 |
| supramolecular complex | 1 |
| centriole | 1 |
| microtubule organizing center | 1 |
| chromosomal region | 1 |
| intracellular anatomical structure | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
428 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| BOD1L2 | F5GXT2 | F5GXT2 | 509 |
| BOD1L2 | ZCCHC18 | P0CG32 | 507 |
| BOD1L2 | CFAP276 | Q5T5A4 | 478 |
| BOD1L2 | ZNF729 | A6NN14 | 452 |
| BOD1L2 | C14orf132 | Q9NPU4 | 434 |
| BOD1L2 | ZNF479 | Q96JC4 | 424 |
| BOD1L2 | PTPN20 | Q4JDL3 | 399 |
| BOD1L2 | GARIN5B | Q8N5Q1 | 376 |
| BOD1L2 | TSSK2 | Q96PF2 | 359 |
| BOD1L2 | STARD9 | Q9P2P6 | 357 |
| BOD1L2 | ZNF532 | Q9HCE3 | 346 |
| BOD1L2 | CCDC68 | Q9H2F9 | 340 |
| BOD1L2 | SEC11C | Q9BY50 | 340 |
| BOD1L2 | ZBED8L | Q8TCP9 | 330 |
| BOD1L2 | ZCCHC12 | Q6PEW1 | 325 |
IntAct
19 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| MEOX2 | BOD1L2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| PRKAR1B | BOD1L2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TRAF2 | BOD1L2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| CRX | BOD1L2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| BOD1L2 | LHX4 | psi-mi:“MI:0915”(physical association) | 0.560 |
| LINC03122 | H2AX | psi-mi:“MI:0914”(association) | 0.530 |
| BOD1 | BPGM | psi-mi:“MI:0914”(association) | 0.350 |
| BOD1L2 | BPGM | psi-mi:“MI:0914”(association) | 0.350 |
| BOD1L2 | MEOX2 | psi-mi:“MI:0915”(physical association) | 0.000 |
| BOD1L2 | LHX4 | psi-mi:“MI:0915”(physical association) | 0.000 |
| BOD1L2 | PRKAR1B | psi-mi:“MI:0915”(physical association) | 0.000 |
| BOD1L2 | TRAF2 | psi-mi:“MI:0915”(physical association) | 0.000 |
| BOD1L2 | CRX | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (16): BOD1L2 (Affinity Capture-MS), BOD1L2 (Affinity Capture-MS), BOD1L2 (Two-hybrid), BOD1L2 (Two-hybrid), BOD1L2 (Two-hybrid), BOD1L2 (Two-hybrid), BOD1L2 (Two-hybrid), BOD1L2 (Affinity Capture-MS), BOD1 (Affinity Capture-MS), BPGM (Affinity Capture-MS), DCP1B (Affinity Capture-MS), BOD1L2 (Affinity Capture-MS), FMN2 (Affinity Capture-MS), MSL3 (Affinity Capture-MS), ATG4A (Affinity Capture-MS)
ESM2 similar proteins: A5A6J5, D4AB66, E2RSQ2, F1M5F3, F1N2W9, F1QDI9, I0IUP4, O14795, P17863, P22681, P22682, P49797, Q02040, Q15014, Q24K03, Q2KHI9, Q2KJ58, Q2T9Y1, Q2YDJ8, Q496Y0, Q4KUS2, Q4R578, Q52L14, Q56K12, Q5C9Z4, Q5F3L9, Q5M7C8, Q5R6Y9, Q5R905, Q62768, Q62769, Q66JB6, Q69ZT9, Q6QI89, Q8BND4, Q8BZ60, Q8HXH0, Q8IYS8, Q8N5Y2, Q8VDV3
Diamond homologs: E9Q6J5, Q5SQY2, Q68FB1, Q6AYJ2, Q6DFL2, Q8IYS8, Q8NFC6, Q96IK1
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
5 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 1 |
| Likely pathogenic | 0 |
| Uncertain significance | 4 |
| Likely benign | 0 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (1)
| Variant ID | HGVS | Classification |
|---|---|---|
| 60000 | GRCh38/hg38 18q21.2-21.31(chr18:55575588-57207463)x1 | Pathogenic |
SpliceAI
6 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 18:57147575:A:T | donor_gain | 0.3600 |
| 18:57147871:T:TA | acceptor_gain | 0.3400 |
| 18:57149966:T:G | acceptor_gain | 0.2300 |
| 18:57147089:G:GT | donor_gain | 0.2100 |
| 18:57147574:G:GT | donor_gain | 0.2100 |
| 18:57147820:G:GT | donor_gain | 0.2100 |
AlphaMissense
1128 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 18:57147739:T:C | F143L | 0.900 |
| 18:57147741:C:A | F143L | 0.900 |
| 18:57147741:C:G | F143L | 0.900 |
| 18:57147466:T:C | F52L | 0.794 |
| 18:57147468:T:A | F52L | 0.794 |
| 18:57147468:T:G | F52L | 0.794 |
| 18:57147706:T:C | F132L | 0.749 |
| 18:57147708:C:A | F132L | 0.749 |
| 18:57147708:C:G | F132L | 0.749 |
| 18:57147475:T:C | F55L | 0.748 |
| 18:57147477:C:A | F55L | 0.748 |
| 18:57147477:C:G | F55L | 0.748 |
| 18:57147547:T:C | F79L | 0.642 |
| 18:57147549:T:A | F79L | 0.642 |
| 18:57147549:T:G | F79L | 0.642 |
| 18:57147453:G:C | K47N | 0.636 |
| 18:57147453:G:T | K47N | 0.636 |
| 18:57147425:T:C | L38P | 0.628 |
| 18:57147437:T:A | I42N | 0.606 |
dbSNP variants (sampled 300 via entrez): RS1000350033 (18:57150403 G>A), RS1000450521 (18:57148305 G>A), RS1002901212 (18:57150660 A>G), RS1003179374 (18:57145150 C>T), RS1003266131 (18:57148736 C>A), RS1003624390 (18:57146162 G>A), RS1004040785 (18:57146464 A>G), RS1004532283 (18:57149972 A>G), RS1004741838 (18:57145221 A>G), RS1004875311 (18:57150692 AAC>A), RS1005627181 (18:57146799 C>T), RS1005964184 (18:57145386 C>T), RS1006927348 (18:57147691 A>C), RS1008772572 (18:57147216 C>G,T), RS1008940484 (18:57145646 G>A)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
1 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST006479_52 | Diverticular disease | 1.000000e-07 |
EFO canonical traits (1, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0009959 | diverticular disease |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
3 total (human), top 3 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| butyraldehyde | decreases expression | 1 |
| CGP 52608 | increases reaction, affects binding | 1 |
| Copper Sulfate | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.